Intra Cellular Therapies | Capitale Ordinario

Ordinary Share Capital Cambiamento Data
Acadia Pharmaceuticals USD 16K 0 2023-12
Cytokinetics USD 102K 8K 2023-12
Gilead Sciences USD 1000K 0 2023-09
Halozyme Therapeutics USD 127K 5K 2023-12
Intra Cellular Therapies USD 10K 0 2023-12
RedHill Biopharma USD 4.62M 1.78M 2023-06
Supernus Pharmaceuticals USD 55K 0 2023-12



Intra Cellular Therapies Capitale Ordinario - Valori correnti, dati storici, previsioni, statistiche, grafici e calendario economico - May 2024.